Galindo RJ, Moazzami B, Scioscia MF, Zambrano C, et al. A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c >/=9-15%: DUAL HIGH Trial. Diabetes Care 2023 Jul 17:dc222426. doi: 10.2337/dc22-2426.
PMID: 37459574